Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-24 @ 11:52 PM
NCT ID:
NCT06096051
Eligibility Criteria:
Inclusion Criteria:
* • ≥18 years of age
* ICH (traumatic and spontaneous)
* Administration of at least one dose of 4F-PCC
* Admitted to the MHS between July 1, 2018 and May 30, 2023
* Rivaroxaban or apixaban use prior to admission
Exclusion Criteria:
* • Warfarin or dabigatran use prior to admission
* Prisoners
* Pregnancy
* \<18 years of age
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06096051
Study Brief:
Protocol Section:
NCT06096051